Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 2/27/2026 has been entered.
Current Status of 17/607,815
This Office Action is responsive to amended claims of 1/27/2026.
A Markush Search exists for a compound of formula I-I. The search was extended to the compound:
PNG
media_image1.png
206
373
media_image1.png
Greyscale
. This compounds maps for Formula I-1 wherein s is 1, R1 is -Cl, R2 is hydrogen, n is 1, R3 is C4 alkyl, X is NH, Y is N, and Z is CH.
This compound reads on claims 1, 9, 15, 154, and 155.
Claims 19, 29, 34-35, 38, 42, 45-46, and 151 are withdraw from consideration in accordance with Markush practice.
Priority
The instant application is a national stage entry of PCT/US2020/031029, filed 05/01/2020, which claims priority to U.S. Provisional applications 62/982,858 (filed 2/28/2020), 62/842,855 (filed 5/3/2019), 62/842,858 (filed 5/3/2019), and 62/842,861 (filed 5/3/2019).
The instant claims find support from U.S. provisional application 62/982,858, filed 2/28/2020. Therefore, the effective filing date is 2/28/2020.
Response to Arguments
Applicants’ claim amendments and Remarks of 1/27/2026 are acknowledged and have been considered.
In regard to 102 and 103 rejection, Applicants amended rejected claims 154 and 155 to not include the compound was CAS #1625258-48-1. These rejections are withdrawn.
Response to Amendments
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claims 154 and 155 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Chemical Abstracts (Chemical Abstracts STN REGISTRY Database, Record for 1343461-88-0, entered into STN November 9, 2011).
ACS anticipates the compound with a CAS# of 1343461-88-0,
PNG
media_image1.png
206
373
media_image1.png
Greyscale
. This compounds maps for Formula I-1 wherein s is 1, R1 is -Cl, R2 is hydrogen, n is 1, R3 is C4 alkyl, X is NH, Y is N, and Z is CH. This anticipates claim 154. This compound also anticipates formula I-c in claim 155.
Conclusion
Claims 154, and 155 are rejected. Claims 1, 9, and 15 are allowable. The disposition of these claims is dependent upon not finding other prior art rejections in future Markush Search Extensions.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to GILLIAN A HUTTER whose telephone number is (571)272-6323. The examiner can normally be reached M-F 7:30-5.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Andrew Kosar can be reached at 571-272-0913. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/G.A.H./Examiner, Art Unit 1625 /Andrew D Kosar/Supervisory Patent Examiner, Art Unit 1625
Prosecution Insights